Grifols S.A.

E:GRF 
(MADRID) 
 
28.61
Updated 16/07/2019
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 960,093
High 28.61
Low 28.23
Open 28.49
ISIN ES0171996087
Prev close 28.61
# of shares -
Market cap -
Intraday

Market closed
Grifols S.A.
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  28.61 3.8% Stock price increasing 15.1% Stock price increasing 19.0% Stock price increasing 17.1% Stock price increasing 12.5% Stock price increasing
Powered by TradingView

Company profile

Grifols SA is a Spain-based vertically integrated plasma derivative producer. Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's bioscience business contributed 79% of sales in 2017. Grifols also has smaller segments including diagnostics, hospital supplies, and biosupplies. Diagnostics grew to almost 20% of revenue in 2014 with the acquisition of Novartis' diagnostics unit.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
18 July 2019 06:18:28
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190703.1 - EUROWEB3 - 2019-07-18 07:18:28 - 2019-07-18 06:18:28 - 1000 - Website: OKAY